| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |